FORM 4
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Aguilar Richard
2. Issuer Name and Ticker or Trading Symbol

Cano Health, Inc. [ CANO ]
5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                    _____ 10% Owner
__X__ Officer (give title below)    _____ Other (specify below)
Chief Clinical Officer
(Last)          (First)          (Middle)

CANO HEALTH, INC., 9725 NW 117TH AVENUE
3. Date of Earliest Transaction (MM/DD/YYYY)

6/26/2023
(Street)

MIAMI, FL 33178
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
(City)        (State)        (Zip)
Rule 10b5-1(c) Transaction Indication
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Class A Common Stock 6/26/2023  C  550000 A$0.00 (1)1763984 D  

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security3. Trans. Date3A. Deemed Execution Date, if any4. Trans. Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
6. Date Exercisable and Expiration Date7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
PCIH Common Units  (1)6/26/2023  C     550000   (2) (2)Class A Common Stock 550000 $0.00 4742276 I See Note (3)
Class B Common Stock  (1)6/26/2023  C     550000   (2) (2)Class A Common Stock 550000 $0.00 4742276 I See Note (3)

Explanation of Responses:
(1) Reflects the Reporting Person's exchange of Primary Care (ITC) Intermediate Holdings, LLC ("PCIH Common Units"), together with the surrender and cancellation of the same number of shares of the Issuer's Class B Common Stock, par value $0.0001 per share ("Class B Common Stock"), for an equal number of shares of the Issuer's Class A Common Stock, par value $0.0001 per share ("Class A Common Stock"), pursuant to the Second Amended and Restated Limited Liability Company Agreement of Primary Care (ITC) Intermediate Holdings, LLC (the "LLC Agreement"). Transactions are exempt from Section 16(b) in reliance on Rule 16b-6(b).
(2) PCIH Common Units, together with an equal number of shares of the Class B Common Stock, are exchangeable for shares of Class A Common Stock on a one-for-one basis pursuant to the LLC Agreement. The PCIH Common Units have no expiration date.
(3) These securities are owned directly by Aguilar Borrower Holdings LLC. The Reporting Person has sole voting and dispositive power with respect to all of these securities and therefore is a beneficial owner of these securities.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director10% OwnerOfficerOther
Aguilar Richard
CANO HEALTH, INC.
9725 NW 117TH AVENUE
MIAMI, FL 33178


Chief Clinical Officer

Signatures
/s/ David J. Armstrong, Attorney-in-Fact6/28/2023
**Signature of Reporting PersonDate


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
*If the form is filed by more than one reporting person, see Instruction 4(b)(v).
**Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note:File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
Jaws Acquisition (NYSE:JWS)
Historical Stock Chart
From May 2024 to Jun 2024 Click Here for more Jaws Acquisition Charts.
Jaws Acquisition (NYSE:JWS)
Historical Stock Chart
From Jun 2023 to Jun 2024 Click Here for more Jaws Acquisition Charts.